Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

1cP-AL-LAD

From Wikipedia, the free encyclopedia
Chemical compound

Pharmaceutical compound
1cP-AL-LAD
Clinical data
Routes of
administration
Oral
Drug classSerotonergic psychedelic;Hallucinogen
Identifiers
  • (6aR,9R)-4-(cyclopropanecarbonyl)-N,N-diethyl-7-prop-2-enyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide
PubChemCID
UNII
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC26H31N3O2
Molar mass417.553 g·mol−1
3D model (JSmol)
  • CCN(CC)C(=O)[C@@H]1C=C2[C@@H](Cc3cn(C(=O)C4CC4)c4cccc2c34)N(C1)CC=C
  • InChI=1S/C26H31N3O2/c1-4-12-28-15-19(25(30)27(5-2)6-3)13-21-20-8-7-9-22-24(20)18(14-23(21)28)16-29(22)26(31)17-10-11-17/h4,7-9,13,16-17,19,23H,1,5-6,10-12,14-15H2,2-3H3/t19-,23-/m1/s1
  • Key:VSABTUDYQCMWKE-AUSIDOKSSA-N

1cP-AL-LAD is apsychedelic drug of thelysergamide family related tolysergic acid diethylamide (LSD).[1][2] It is thought to act asprodrug ofAL-LAD.[2]

Use and effects

[edit]
See also:AL-LAD § Use and effects

Interactions

[edit]
See also:Psychedelic drug § Interactions, andTrip killer § Serotonergic psychedelic antidotes

Chemistry

[edit]

Analogues

[edit]

Related compounds include1cP-LSD,1D-LSD,1P-AL-LAD, and1T-AL-LAD, among others.

History

[edit]

1cP-AL-LAD has been sold as adesigner drug.[1] It was first identified inFrance in June 2021.[1]

See also

[edit]

References

[edit]
  1. ^abcMorais J, Evans-Brown M, Gallegos A, Christie R, Jorge R, Planchuelo G, et al. (2022-09-01)."New psychoactive substances: 25 years of early warning and response in Europe. An update from the EU Early Warning System".Toxicologie Analytique et Clinique. 30th meeting of SFTA- 59th meeting of TIAFT - September 2022.34 (3, Supplement):S29 –S30.Bibcode:2022ToxAC..34S..29M.doi:10.1016/j.toxac.2022.06.022.ISSN 2352-0078.
  2. ^abKavanagh PV, Westphal F, Pulver B, Schwelm HM, Stratford A, Auwärter V, et al. (March 2023). "Analytical profile of the lysergamide 1cP-AL-LAD and detection of impurities".Drug Test Anal.15 (3):277–291.doi:10.1002/dta.3397.PMID 36321499.

External links

[edit]
Tryptamines
No ring subs.
4-Hydroxytryptamines
5-Hydroxytryptamines
5-Methoxytryptamines
Other ring subs.
α-Alkyltryptamines
Others
Cyclized
Bioisosteres
Phenethylamines
Scalines
2C-x
3C-x
DOx
4C-x
Ψ-PEA
MDxx
FLY
25x-NB (NBOMes)
Others
Cyclized
Lysergamides
  • Bioisosteres:JRT
Others
Natural sources
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
D1-like
Agonists
PAMs
Antagonists
D2-like
Agonists
Antagonists
Ergolines
(incl.lysergines)
Clavines
(6,8-dimethylergolines)
Lysergamides
(lysergic acid amides)
Ergopeptines
(peptide ergolines)
Partial ergolines
Related compounds
Natural sources
Retrieved from "https://en.wikipedia.org/w/index.php?title=1cP-AL-LAD&oldid=1321062448"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp